Extension to the AzureSeq-200 CE One-step RT-qPCR Assay

26/03/2021

Omixon and SeqOnce Biosciences Announce an Extension to the AzureSeq-200 CE One-step RT-qPCR Assay to Detect SARS-CoV-2 E484K N501Y mutations and K417 wildtype Assay quickly identifies the E484K, N501Y mutations and K417 wildtype found in U.K., South Africa, and Brazil lineages of SARS-CoV-2 Transplantation was severely affected by the...

Omixon Launches AzureSeq-200 CE IVD Kit For One-step RT-qPCR Detection of SARS-CoV-2 and Announces Exclusive Agreement with SeqOnce Biosciences

05/10/2020

As much as Omixon wants to stay focused on the needs of histocompatibility labs, the current coronavirus pandemic calls for innovation in the field of viral detection based on molecular diagnostics. Omixon has used its product development capabilities and collaboration network to develop a truly innovative product addressing an...

HLA EXPLORE™ can help you in your COVID research and Omixon offers 50% off the annual licence fee for Research Institutions until the end of 2020

28/05/2020

HLA Explore NGS software can analyze any experiment type – targeted exons, targeted whole genes, whole MHC, whole transcriptome, whole exome or whole genome – of your patient’s NGS samples. While recovering from the COVID crises Omixon offers 50% off the annual licence fee for Research Institutions until the...

How Genetic Variation in the Immune System Predicts COVID-19 Disease Outcome

23/03/2020

Authors: Csaba Pal, Mate Manczinger, Attila Berces As we all know, the COVID-19 infectious disease caused by the SARS-CoV2 virus has spread globally. It is a significant and urgent medical threat with serious implications on our personal life and global economy. Therefore, it is of paramount importance to identify...